guiding you onto the right path

Latest Jobs

Purpose: Acting as the key interface with clients over projects, manages the timely delivery of project outputs in line with client expectations. Dev...
Purpose: Manages the delivery of client project(s), ensuring delivery of the project in line with client objectives and expectations as well as proje...

SENIOR ASSOCIATE

Purpose:

Manages the delivery of client project(s), ensuring delivery of the project in line with client objectives and expectations as well as project timelines. Working closely with the project lead / EM, the Project Manager (PM) serves as the key point of contact for the project, manages the client relationship throughout the term of the project and manages the project team. Senior Associates will also be members of other teams to support the delivery of projects by conducting research, analyzing findings to generate insights and pulling together client deliverables.

 

Key Accountabilities:

Project Planning ? In partnership with the EM, drafts a robust project plan, to include key milestones / delivery points ? Accurately forecasts resource and capacity needed to deliver the project, in partnership with the EM ? Resources the project team, working with proposed team members’ line managers to ensure the project is aligned with capacity limitations, capabilities and development needs ? Identifies potential project risks and raises these with the EM

Project Delivery ? Leads team analysis meetings to ensure rigorous analysis of all data gathered and generate meaningful insights for the client ? Monitors project progress against the plan, identifying any risks / red flags and informing and/or involving the EM as appropriate ? Maps out the research and output needed to complete the project ? Monitors actual capacity against forecasted and flags variances with the EM to ensure Tenrox work plans are accurate and up-to-date ? Communicates regularly with the project team (including the EM / project lead) to ensure the all team members are fully up-to-speed with project progress

 

Client Management ? Acts as the key point of contact on the project, addressing any questions / concerns and flagging issues with the EM as appropriate ? Leads project status update meetings, both internally and externally ? Builds relationships with the client project team through delivering quality work, regular follow-ups and updates, etc. ? Ensures client satisfaction throughout the term of the project 

Thinking & Analysis ? Using a range of strategic frameworks, conceptualizes complex data into simplistic, digestible and meaningful insights for clients ? Manages a research team to ensure

People Management ? Delegates project delivery to the project team based on the project plan ? Manages project team members to deliver the project against agreed timeliness and objectives ? Provides feedback to project team members on a regular basis to support their continued development ? Proactively addresses any performance issues in team members, linking in with the individual’s line manager ? Provides development opportunities for project team members, as appropriate ? Communicates key project updates with project team, to ensure alignment and shared understanding of project objectives/status/final outputs of all projectteam members and

Project Review ? Conducts project reviews at the close of every project (or at contract renewal for monitoring projects) to ensure key learnings from the project are captured ? Provides formal feedback to all team

Experience managing projects or streams of work within projects ? Advanced degree in life sciences or business or 2-5 years’ industry experience ? Highly proficient in MS Office (to include Excel and PowerPoint)

Job Type:
Permanent
Experience:
PhD
Location:
London
Sector:
Market Access & Pricing Reimbursement
Salary:
£Negotiable
Ref:
105905

How to apply

Apply Now

Latest News

Fri, 13 Jun 2025 10:00:00 +0200
A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington's disease and improve the efficiency of clinical trials, finds research led by scientists at University College London (UCL) and Roche.

The research, published in Brain, highlights how digitising tests designed to measure the progression of motor symptoms in people with Huntington's disease can provide a sensitive and reliable way to track changes in the function of patients.

Thu, 12 Jun 2025 10:00:00 +0200
BayerVividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, announced it has secured exclusive worldwide rights to develop and commercialize the clinical-stage Werner helicase (WRN) covalent inhibitor VVD-214 (RO7589831), strengthening and complementing its innovative oncology development pipeline. VVD-214 was discovered and developed under an exclusive worldwide collaboration and license agreement initiated between Vividion and Roche in 2020.
Wed, 11 Jun 2025 10:00:00 +0200
We have all heard of antibodies - proteins produced by our bodies to bind to viruses or bacteria, marking them for elimination by the immune system. But not all of us are familiar with aptamers: short segments of DNA or RNA that are designed to bind, like antibodies, to specific targets. Synthetic and inexpensive to produce, aptamers are attractive alternatives to antibodies for biomedical diagnostics and therapeutics.
Tue, 10 Jun 2025 10:00:00 +0200
Food scientists at the University of Illinois Urbana-Champaign identified the optimal fermentation conditions for pulses - the dried edible seeds of legumes - that increased their antioxidant and antidiabetic properties and their soluble protein content.

Using the bacteria Lactiplantibacillus plantarum 299v as the microorganism, the team fermented pulses obtained from varying concentrations of black bean, black-eyed pea, green split pea, red lentil and pinto bean flours.

Mon, 09 Jun 2025 10:00:00 +0200
In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for more tools for their arsenal. The strong antibody responses generated by vaccines provide an important first round of defense, but "you always want to have a backup plan," says Biomedical Graduate Studies Ph.D. student Emily A. Aunins, considering viruses mutate to evade antibody responses that become widespread in a population.
Fri, 06 Jun 2025 10:00:00 +0200
SanofiNew data from 18 abstracts, including five oral presentations, will be presented at the 33rd congress of the International Society on Thrombosis and Haemostasis (ISTH) in Washington D.C., US from June 21 to 25, 2025, highlighting Sanofi as a leader in hemophilia committed to rare blood diseases. Data to be presented expand on the potential of rilzabrutinib to address the underlying immune dysregulation of immune thrombocytopenia (ITP) and strengthen Sanofi as a leader in hemophilia with ALTUVIIIO and the newly launched Qfitlia, aimed at providing more treatment options to help improve patients' lives.
Thu, 05 Jun 2025 10:00:00 +0200
Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing multiple myeloma, the second most common type of blood cancer. The study showed that the diet was not only feasible and well-received but also improved several factors that could potentially delay the progression of precancerous conditions that can lead to multiple myeloma.
Wed, 04 Jun 2025 10:00:00 +0200
University of Otago - Ōtākou Whakaihu Waka researchers have been part of two groundbreaking studies in the battle against drug resistant strains of Mycobacterium tuberculosis, the cause of tuberculosis.

Co-author on both studies, Dr Matthew McNeil, of the Department of Microbiology and Immunology, describes tuberculosis as a "massive public health problem" that is challenging to solve.

Tue, 03 Jun 2025 10:00:00 +0200
New research has found that those who consume a diverse range of foods rich in flavonoids, such as tea, berries, dark chocolate, and apples, could lower their risk of developing serious health conditions and have the potential to live longer.

The study was led by a team of researchers from Queen's University Belfast, Edith Cowan University Perth (ECU), and the Medical University of Vienna.

Mon, 02 Jun 2025 10:00:00 +0200
Understanding and preventing drug side effects holds a profound influence on drug development and utilization, profoundly impacting patients' physical and mental well-being. Traditional artificial drug experimentation methods are not only expensive but also time-consuming, rendering comprehensive testing a challenging task.
Fri, 30 May 2025 10:00:00 +0200
A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm - Future Medicine. The article comprehensively evaluates DeepSeek-R1, a Chinese-developed open-source large language model (LLM), and its potential to transform the healthcare landscape.
Thu, 29 May 2025 10:00:00 +0200
BayerBayer announced that the investigational compound sevabertinib (BAY 2927088) has been granted Priority Review status by the US Food and Drug Administration (FDA) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumors have activating human epidermal growth factor receptor 2 (HER2/ERBB2) mutations and who have received a prior systemic therapy.[1] Sevabertinib is an oral, small molecule, tyrosine kinase inhibitor (TKI).
Wed, 28 May 2025 10:00:00 +0200
A study led by a physician-scientist at the University of Arizona College of Medicine - Tucson's Sarver Heart Center identified a drug candidate that appears to reverse the progression of a type of heart failure in mouse models, which could lead to expanded treatment options for humans. The results were published in the journal Cell Metabolism.
Tue, 27 May 2025 10:00:00 +0200
Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's Disease (AD) and other conditions that destroy cells in the brain and nervous system.

While there is no treatment to control or manage these neurodegenerative conditions, investigators at Case Western Reserve University, University Hospitals and the Louis Stokes Cleveland VA Medical Center have identified a new and promising drug to treat AD.

Mon, 26 May 2025 10:00:00 +0200
A widely used antidepressant drug could help the immune system fight cancer, according to a new UCLA research study.

Selective serotonin reuptake inhibitors, or SSRIs, significantly enhanced the ability of T cells to fight cancer and suppressed tumor growth across a range of cancer types in both mouse and human tumor models, the study, published in Cell, found.

Fri, 23 May 2025 10:00:00 +0200
PfizerPfizer Inc. (NYSE: PFE) announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the development, manufacturing and commercialization of SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, currently undergoing several clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors.
Thu, 22 May 2025 10:00:00 +0200
As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the disease and improved memory in mice by boosting production of a protective protein.

In a study published in the Nature journal npj Drug Discovery, UCLA Health researchers targeted the protein clusterin (CLU), which is crucial in preventing the build-up of amyloid-beta plaques and

Wed, 21 May 2025 10:00:00 +0200
Purdue University's College of Pharmacy is now home to the Center for Research Innovation in Biotechnology and the Clinical Drug Experience Knowledgebase (CDEK), a comprehensive database of every active pharmaceutical ingredient with evidence of clinical testing.

The center, or CRIB, is a collaborative effort between Purdue and Stony Brook universities.

Tue, 20 May 2025 10:00:00 +0200
A drug used to treat type 2 diabetes may also be effective in slowing the progression of prostate cancer. This is shown by an international study in which researchers at Umeå University, Sweden, have participated. The researchers have found that drugs that regulate a particular protein have a key role in reducing prostate cancer recurrence among diabetic patients.
Mon, 19 May 2025 10:00:00 +0200
Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient.

In a new paper, Xia Ning, lead author of the study and a professor of biomedical informatics and computer science and engineering at The Ohio State University, introduces DiffSMol, a generative AI model capable of generating realistic 3D structures of small molecules that can serve as promising drug candidates.

Upload Your CV

Need help finding that new job? Leave your details with us and request a call back from one of our consultants.

Submit A Vacancy

Looking to expand? Or a vacancy has become available in your business then let us know and we can find the right person for you